- Home
- SOTK vs AVTX Comparison
SOTK vs AVTX Comparison
Compare SOTK & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- AVTX
- Stock Information
- Founded
- SOTK 1975
- AVTX 2011
- Country
- SOTK United States
- AVTX United States
- Employees
- SOTK N/A
- AVTX N/A
- Industry
- SOTK Industrial Machinery/Components
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- AVTX Health Care
- Exchange
- SOTK Nasdaq
- AVTX Nasdaq
- Market Cap
- SOTK 58.1M
- AVTX 57.4M
- IPO Year
- SOTK 1987
- AVTX 2015
- Fundamental
- Price
- SOTK $3.96
- AVTX $4.95
- Analyst Decision
- SOTK Buy
- AVTX Strong Buy
- Analyst Count
- SOTK 1
- AVTX 7
- Target Price
- SOTK $7.50
- AVTX $34.33
- AVG Volume (30 Days)
- SOTK 6.1K
- AVTX 61.9K
- Earning Date
- SOTK 05-22-2025
- AVTX 05-12-2025
- Dividend Yield
- SOTK N/A
- AVTX N/A
- EPS Growth
- SOTK N/A
- AVTX N/A
- EPS
- SOTK 0.07
- AVTX N/A
- Revenue
- SOTK $20,151,145.00
- AVTX $441,000.00
- Revenue This Year
- SOTK $6.11
- AVTX N/A
- Revenue Next Year
- SOTK $9.27
- AVTX N/A
- P/E Ratio
- SOTK $55.87
- AVTX N/A
- Revenue Growth
- SOTK 8.40
- AVTX N/A
- 52 Week Low
- SOTK $3.50
- AVTX $4.15
- 52 Week High
- SOTK $6.05
- AVTX $17.49
- Technical
- Relative Strength Index (RSI)
- SOTK 70.44
- AVTX 37.57
- Support Level
- SOTK $3.50
- AVTX $4.15
- Resistance Level
- SOTK $3.76
- AVTX $5.85
- Average True Range (ATR)
- SOTK 0.13
- AVTX 0.77
- MACD
- SOTK 0.05
- AVTX -0.07
- Stochastic Oscillator
- SOTK 100.00
- AVTX 28.05
About SOTK Sono-Tek Corporation
Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).